Tougher rules for Poland's private sector:
This article was originally published in Clinica
The private healthcare sector in Poland will have to tighten up its purchasing requirements later this year. A new regulation due out soon will mean it has to comply with the same regulations as the public sector and only purchase products that have received premarket approval from the authorities. At present it is free to buy products whether they have been approved or not.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.